Brand: ProteoGenix

Pepinemab Biosimilar – Anti-SEMA4D mAb – Research Grade

Clonality:: Monoclonal Antibody
Isotype:: IgG4, Kappa

$238.00

+ 238 loyalty points

Size Size

100ug $238.00
1MG $952.00

First Name This field is required. Last Name This field is required. Email This field is required. Company This field is required. Country This field is required. State This field is required.

In Stock
Wide range of unique reagents
Fast worldwide delivery

SDS-PAGE for Pepinemab Biosimilar - Anti-SEMA4D mAb

Pepinemab Biosimilar - Anti-SEMA4D mAb - Research Grade

Product name	Pepinemab Biosimilar - Anti-SEMA4D mAb - Research Grade
Source	CAS 2097151-87-4
Species	Humanized
Purity	>85%
Buffer	PBS buffer PH7.5
Delivery condition	Blue ice (+4°C)
Delivery Time	3-5 days if in stock; 3-5 weeks if production needed
Storage condition	store at -80°C
Brand	ProteoGenix
Applications	ELISA,WB
Aliases /Synonyms	Pepinemab ,VX-15,VX15/2503,SEMA4D,anti-SEMA4D
Reference	PX-TA1382
Note	For research use only. Not suitable for clinical or therapeutic use.
Isotype	IgG4-kappa
Clonality	Monoclonal Antibody

Product name	Pepinemab Biosimilar - Anti-SEMA4D mAb - Research Grade
Source	CAS 2097151-87-4
Species	Humanized
Purity	>85%
Buffer	PBS buffer PH7.5
Delivery condition	Blue ice (+4°C)
Delivery Time	3-5 days if in stock; 3-5 weeks if production needed
Storage condition	store at -80°C
Brand	ProteoGenix
Applications	ELISA,WB,,,
Aliases /Synonyms	Pepinemab ,VX-15,VX15/2503,SEMA4D,anti-SEMA4D
Reference	PX-TA1382
Note	For research use only. Not suitable for clinical or therapeutic use.
Isotype	IgG4-kappa
Clonality	Monoclonal Antibody

General information on Anti-SEMA4D[Homo sapiens] (Pepinemab ) Monoclonal Antibody

Pepinemab is investigated for the treatment of Resectable Stage IIIB-D Melanoma with or without Ipilimumab and/or Nivolumab.

SDS-PAGE for Pepinemab Biosimilar - Anti-SEMA4D mAb

Pepinemab Biosimilar - Anti-SEMA4D mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

In vivo screening of tumor-hepatocyte interactions identifies Plexin B2 as a gatekeeper of liver metastasis, Costanza Borrelli, Morgan Roberts, Davide Eletto, Atefeh Lafzi, Jonas A. Kretz, Hassan Fazilaty, Marie-Didiée Hussherr, Elena Guido Vinzoni, Kristina Handler, Jan Michler, Srivathsan Adivarahan, Salvatore Piscuoglio, Xenia Ficht, Andreas E. Moor, bioRxiv 2023.05.15.540681; doi: https://doi.org/10.1101/2023.05.15.540681

There are no reviews yet.

Be the first to review “Pepinemab Biosimilar – Anti-SEMA4D mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Your rating *

In which application did you use the antibody? *

Did it work in your application? * Yes No

Your review *

Name *

Email *

Pepinemab Biosimilar – Anti-SEMA4D mAb – Research Grade

Pepinemab Biosimilar - Anti-SEMA4D mAb - Research Grade

General information on Anti-SEMA4D[Homo sapiens] (Pepinemab ) Monoclonal Antibody

SDS-PAGE for Pepinemab Biosimilar - Anti-SEMA4D mAb

Related products

Human CD100-SEMA4D recombinant protein

Human IgG4 Isotype Control antibody

Recently viewed products

Can’t find what you need?

Cart (0 Items)

Pepinemab Biosimilar – Anti-SEMA4D mAb – Research Grade

Specifications Pepinemab Biosimilar - Anti-SEMA4D mAb - Research Grade

Description

General information on Anti-SEMA4D[Homo sapiens] (Pepinemab ) Monoclonal Antibody

Documents

QC & Validation

SDS-PAGE for Pepinemab Biosimilar - Anti-SEMA4D mAb

Publications

Reviews

Related products

Human CD100-SEMA4D recombinant protein

Human IgG4 Isotype Control antibody

Recently viewed products

Can’t find what you need?

Cart (0 Items)

Pepinemab Biosimilar - Anti-SEMA4D mAb - Research Grade